Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core LaboratoriesCLB -2.41%62 Equity-to-Asset is 0.47 as of Jun. 2026, which is 74% above its 10-year median of 0.27. GuruFocus rates CLB with a GF Score™ of 62/100 and a GF Value™ of $17.18 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,027 Oil & Gas companies, Core Laboratories ranks worse than 52.48% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Core Laboratories's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $272.7 Mil. Core Laboratories's Total Assets for the quarter that ended in Jun. 2026 was $586.8 Mil.
Therefore, Core Laboratories's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.47.
The historical rank and industry rank for Core Laboratories's Equity-to-Asset or its related term are showing as below:
CLB'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.1 Med: 0.27 Max: 0.47
Current: 0.47
During the past 13 years, the highest Equity to Asset Ratio of Core Laboratories was 0.47. The lowest was 0.10. And the median was 0.27.
CLB's Equity-to-Asset is ranked worse than 52.48% of 1027
companies
in the Oil & Gas industry
Industry Median: 0.49
vs CLB: 0.47
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Core Laboratories Equity-to-Asset Related Terms
Core Laboratories Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories Equity-to-Asset vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Core Laboratories's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Core Laboratories's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories (CLB) has a Equity-to-Asset of 0.47 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Core Laboratories and its competitors. This is 74% above median its historical median of 0.27. Over the past decade, Core Laboratories' Equity-to-Asset has ranged from 0.10 to 0.47. According to the industry distribution chart, Core Laboratories ranks #539 out of 1027 companies in the Oil & Gas industry, placing it in the top 52.5%.
Is Core Laboratories' Equity-to-Asset too high?
Core Laboratories' current Equity-to-Asset of 0.47 is 74% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.47. The Oil & Gas industry median Equity-to-Asset is 0.49. Core Laboratories' value of 0.47 is 4.1% below this industry median. Based on the distribution chart, Core Laboratories ranks #539 out of 1027 companies in the Oil & Gas industry, which is below the industry midpoint. Overall, Core Laboratories has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Equity-to-Asset compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #539 out of 1027 companies for Equity-to-Asset. This places Core Laboratories in the lower half of its industry. The industry median Equity-to-Asset is 0.49. Core Laboratories' value of 0.47 is 4.1% below this benchmark. Historically, Core Laboratories' own Equity-to-Asset has ranged from 0.10 to 0.47 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 0.49, Core Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for an Oil & Gas company?
The median Equity-to-Asset among Oil & Gas companies is 0.49, based on 1,027 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Equity-to-Asset of 0.47 is 4.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Equity-to-Asset is 0.47, which is 74% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.18, compared to a current price of $10.95 — trading 36.3% below its estimated fair value. The current Equity-to-Asset is 0.47, which is 74% above median its 10-year median of 0.27 and 4.1% below the Oil & Gas industry median of 0.49. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Core Laboratories (CLB), the current Equity-to-Asset is 0.47 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of $10.95 is trading 36.3% below its estimated GF Value™ of $17.18.
GuruFocus considers Core Laboratories to be Significantly Undervalued.
Key valuation signals for CLB:
Equity-to-Asset: 0.47 (74% above median its 10-year median of 0.27)
GF Value™: $17.18 vs. price of $10.95 (36.3% below fair value)
Industry Position: 4.1% below the Oil & Gas median (#539 of 1027)
No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for CLB
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLB has been successfully added to your 
